Peter Bohlen
32Patents
18h-index
26Co-inventors
81Inventor score
Filing activity: Jun 14, 1980 → May 20, 2011
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5155214A | Basic fibroblast growth factor | Human Necessities | 84 | Expired |
| US4316891A | Extended N-terminal somatostatin | Emerging Cross-Sectional Technologies | 64 | Expired |
| US5310883A | Chimeric fibroblast growth factors | Human Necessities | 53 | Expired |
| US6010999A | Stabilization of fibroblast growth factors by modification of cysteine residues | Chemistry; Metallurgy | 46 | Expired |
| US4785079A | Isolation of fibroblast growth factor | Chemistry; Metallurgy | 46 | Expired |
| US5491220A | Surface loop structural analogues of fibroblast growth factors | Human Necessities | 44 | Expired |
| US5574026A | Methods for inhibiting angiogenesis proliferation of endothelial or tumor cells and tumor growth | Human Necessities | 42 | Expired |
| US5302702A | Chimeric fibroblast growth factors | Human Necessities | 39 | Expired |
| US4956455A | Bovine fibroblast growth factor | Emerging Cross-Sectional Technologies | 35 | Expired |
| US5843925A | Methods for inhibiting angiogenesis, proliferation of endothelial or tumor cells and tumor growth | Human Necessities | 32 | Expired |
| US5387673A | Active fragments of fibroblast growth factor | Human Necessities | 27 | Expired |
| US4517181A | Mammalian PGRF | Emerging Cross-Sectional Technologies | 26 | Expired |
| US5567693A | Method for inhibiting angiogenesis, proliferation of endothelial or tumor cells and tumor growth | Human Necessities | 24 | Expired |
| US4585756A | Bovine GRF | Emerging Cross-Sectional Technologies | 20 | Expired |
| US4610976A | Porcine GRF | Emerging Cross-Sectional Technologies | 20 | Expired |
| US5464774A | Bovine basic fibroblast growth factor | Human Necessities | 18 | Expired |
| US5371206A | DNA encoding chimeric fibroblast growth factors | Human Necessities | 18 | Expired |
| US4902782A | Isolation of fibroblast growth factor | Emerging Cross-Sectional Technologies | 18 | Expired |
| US5563130A | Methods for inhibiting angiogenesis, proliferation of endothelial or tumor cells and tumor growth | Human Necessities | 16 | Expired |
| US4605643A | Ovine GRF | Emerging Cross-Sectional Technologies | 16 | Expired |
| US4675383A | Purification of T-cell growth factor | Chemistry; Metallurgy | 15 | Expired |
| US5210026A | Human MK gene and method of expression | Human Necessities | 15 | Expired |
| US5951972A | Stabilization of somatotropins and other proteins by modification of cysteine residues | Chemistry; Metallurgy | 14 | Expired |
| US5856315A | Methods for inhibiting proliferation of tumor cells and tumor growth | Human Necessities | 14 | Expired |
| US7972596B2 | Antibodies against vascular endothelial growth factor receptor-1 | Chemistry; Metallurgy | 7 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.